Mebias Discovery, Inc. — Form D
Mebias Discovery, Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2022-09-23. The offering totals $2.0M, of which $631K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2022-09-23
- Form: D
- Accession: 0001782138-22-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $631K
- Remaining: $1.4M
- Investors: 2
- Date of first sale: 2022-09-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-459737
Issuer
- Name: Mebias Discovery, Inc.
- CIK: 0001782138
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 3675 MARKET STREET, SUITE 200, PHILADELPHIA, PA, 19104
- Phone: 267-218-0854
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Guanghui A Hu | Director | Philadelphia, PA |
| Barbara A Schilberg | Director | Philadelphia, PA |
| Brett A Tounge | Director | Philadelphia, PA |
| Shariff S Bayoumy | Executive Officer | Philadelphia, PA |
| Lawrence C Kuo | Executive Officer | Philadelphia, PA |
| Brett A Tounge | Executive Officer | Philadelphia, PA |
| Michael A Serrano-Wu | Director | Philadelphia, PA |
Other filings by this issuer (1)
More